title: Do the benefits gained using a short-term pulmonary rehabilitation program remain in COPD patients after participation?
abstract: The aim of this study was to evaluate the short-term benefits of a pulmonary rehabilitation program in chronic obstructive pulmonary disease (COPD) patients. The study was a randomized controlled trial that included 54 mild and moderate COPD patients. Patients were assigned to either an 8-week-long pulmonary rehabilitation program, which consisted of exercise plus education (rehabilitation group), or were controls. All the patients were evaluated at baseline at the completion of the 8th week of the program and one month after the completion of the pulmonary rehabilitation program using five instruments: arterial blood gas analysis, postbronchodilator pulmonary function test, 6-minute walk test (6MWT), Saint George Respiratory Questionnaire (SGRQ), and the dyspnea visual analog scale (VAS) There were no statistically significant differences in the pulmonary functions and pulmonary gas analysis between baseline, discharge (8th week), and the 12th-week visit in both groups (p > 0.05). Rehabilitation resulted in significant improvements in both the VAS and the 6MWT at the 8th week, but by the 12th week all of these improvements had deteriorated. All of the SGRQ domains improved both at the 8th and the 12th week, with a significant difference between the groups (p < 0.05). We conclude that rehabilitation resulted in improvements in exercise capacity, health status, and dyspnea. All of these benefits, however, tend to deteriorate in the first month after rehabilitation. Therefore, it is strongly recommended that all patients with COPD be kept motivated in order to continue with rehabilitation and maintain the benefits gained.
authors.affiliation: Physical Medicine and Rehabilitation Department, Ege University Medical Faculty, 35100 Bornova, Izmir, Turkey. haleuzum76@hotmail.com
authors.forename: Hale
authors.initials: H
authors.lastname: Karapolat
authors.forename: Alev
authors.initials: A
authors.lastname: Atasever
authors.forename: Funda
authors.initials: F
authors.lastname: Atamaz
authors.forename: Yeşim
authors.initials: Y
authors.lastname: Kirazli
authors.forename: Funda
authors.initials: F
authors.lastname: Elmas
authors.forename: Ertürk
authors.initials: E
authors.lastname: Erdinç
mesh_terms: D000368:Aged; D004417:Dyspnea; D005081:Exercise Therapy; D017079:Exercise Tolerance; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D010353:Patient Education as Topic; D029424:Pulmonary Disease, Chronic Obstructive / Q000503:physiopathology / Q000534:rehabilitation*; D011788:Quality of Life; D012129:Respiratory Function Tests
chemical_list: D010100:Oxygen